Vaksin COVID-19 Johnson & Johnson
Vaksin COVID-19 Johnson & Johnson

Vaksin COVID-19 Johnson & Johnson

Vaksin COVID-19 Johnson & Johnson ialah vaksin COVID-19 vektor virus adenovirus manusia[10] yang dibangunkan oleh Janssen Vaccines di Leiden, Belanda,[11] dan syarikat induknya di Belgium, Janssen Pharmaceuticals,[12] anak syarikat milik syarikat farmaseutikal Amerika Syarikat Johnson & Johnson (J&J).[13][14]Vaksin tersebut mengandungi bahan asas adenovirus manusia yang diubahsuai untuk membuat gen untuk mencipta protein terhadap virus SARS-CoV-2 yang menyebabkan COVID-19. Vaksin tersebut hanya diwajibkan satu dos dan tidak perlu disimpan beku.

Vaksin COVID-19 Johnson & Johnson

Status perundangan
  • KA: Schedule D; Authorized by interim order [5][6]
  • AS: Tidak disepakati (Penguatkuasaan Penggunaan Darurat)[7][1][8]
  • EU: Otorisasi pemasaran kondisional diberikan [9]
Nama dagang Janssen COVID-19 Vaccine,[1][2] COVID-19 Vaccine Janssen
Kaedahpemberian Intraotot
DrugBank
Penyakit sasaran SARS-CoV-2
Data lesen
Nama lain
Kod ATC
UNII
Jenis viral

Rujukan

WikiPedia: Vaksin COVID-19 Johnson & Johnson https://covid-vaccine.canada.ca/info/pdf/janssen-c... https://covid-vaccine.canada.ca/info/regulatory-de... https://www.drugbank.ca/drugs/DB15857 https://www.bostonglobe.com/2020/03/12/business/be... https://www.janssen.com/belgium/clinical-trial-cov... https://www.janssencovid19vaccine.com/hcp.html https://www.jnj.com/coronavirus/ensemble-1-study-p... https://www.jnj.com/coronavirus/ensemble-2-study-p... https://www.nytimes.com/interactive/2020/health/jo... https://www.ema.europa.eu/en/medicines/human/EPAR/...